Page last updated: 2024-09-26

i-677

Description

4-oxalysine: from Streptomyces reseoviridofuscus; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

O-(2-aminoethyl)-L-serine : An L-alpha-amino acid that is L-serine in which the hydroxy group at position 3 is converted to the corresponding 2-aminoethyl ether. An antimetabolic antibiotic obtained from Streptomyces reseoviridofuscus. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160555
CHEMBL ID1234985
CHEBI ID72341
SCHEMBL ID479185
MeSH IDM0088454

Synonyms (33)

Synonym
997-44-4
l-serine, o-(2-aminoethyl)-
(l)-3-(2-aminoethoxy)alanine
o-(2-aminoethyl)-l-serine
alanine, 3-(2-aminoethoxy)-, l-
i 677
chebi:72341 ,
CHEMBL1234985
oxalysine-l
i-677
olz ,
NCGC00014348
l-4-oxalysine
nsc-136035
NCI136035
NCISTRUC1_000654
NCISTRUC2_000650
NCGC00097457-01
(2s)-2-amino-3-(2-aminoethoxy)propanoic acid
15219-97-3
AKOS006237370
l-3-(2-aminoethoxy)alanine
(s)-2-amino-3-(2-aminoethoxy)propionic acid
(s)-2-amino-3-(2-aminoethoxy)propanoic acid
4-oxalysine
serine, o-(2-aminoethyl)-
CCG-37546
NCGC00014348-02
SCHEMBL479185
(s)-(+)-2-amino-3-(2-aminoethoxy)propanoic acid
o-(2-aminoethyl)serine
DTXSID00912533
Q27139916

Roles (4)

RoleDescription
antimetaboliteA substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
L-serine derivativeA proteinogenic amino acid derivative resulting from reaction of L-serine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-serine by a heteroatom.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID513353Binding affinity to lysine riboswitch 179 lysc of Bacillus subtilis 168 M1 harboring G163A mutation in P4 motif2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513349Antibacterial activity against Bacillus subtilis 168 M2 harboring adenosine deletion within 95 to 97 sequence in loop E of P2 motif after 24 hrs by CLSI method2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513350Inhibition of lysine riboswitch 179 lysc in Bacillus subtilis 168 M1 harboring G163A mutation in P4 motif assessed as reduction of beta-galactosidase activity at 5 mM after 3 hrs by lacZ reporter gene assay2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID1204898Antibacterial activity against Bacillus subtilis in chemical defined medium2015Journal of medicinal chemistry, Apr-23, Volume: 58, Issue:8
(Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
AID513359Antibacterial activity against wild type Bacillus subtilis 168 1A1 assessed as inhibition of viable spore formation at 2 mM after 22 to 24 hrs2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513354Binding affinity to lysine riboswitch 179 lysc of Bacillus subtilis 168 M2 harboring adenosine deletion within 95 to 97 sequence in loop E of P2 motif2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513347Antibacterial activity against wild type Bacillus subtilis 168 1A1 assessed as inhibition of viable spore formation at 0.2 mM after 22 to 24 hrs2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513346Inhibition of wild-type Bacillus subtilis 168 1A1 lysine riboswitch 179 lysc assessed as reduction of beta-galactosidase activity at 5 mM after 3 hrs by lacZ reporter gene assay2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513348Antibacterial activity against Bacillus subtilis 168 M1 harboring G163A mutation in P4 motif after 24 hrs by CLSI method2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID1204889Binding affinity to lysC riboswitch in Bacillus subtilis2015Journal of medicinal chemistry, Apr-23, Volume: 58, Issue:8
(Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.
AID513344Antibacterial activity against Bacillus subtilis 168 1A1 at 100 uM after 24 hrs by by CLSI method2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513352Binding affinity to Bacillus subtilis 168 1A1 lysine riboswitch 179 lysc2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513351Inhibition of lysine riboswitch 179 lysc in Bacillus subtilis 168 M2 harboring adenosine deletion within 95 to 97 sequence in loop E of P2 motif assessed as reduction of beta-galactosidase activity at 5 mM after 3 hrs by lacZ reporter gene assay2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513360Antibacterial activity against L-4-oxalysine-resistant Bacillus subtilis 168 M2 assessed as inhibition of viable spore formation at 2 mM after 22 to 24 hrs2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513345Antibacterial activity against Bacillus subtilis 1A40 at 1 mM after 3 hrs by CLSI method2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513357Antibacterial activity against Bacillus subtilis 168 1A1 after 24 hrs by CLSI method2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
AID513343Binding affinity to Bacillus subtilis 168 1A1 lysine riboswitch 179 lysc by in-line probing assay2007Nature chemical biology, Jan, Volume: 3, Issue:1
Antibacterial lysine analogs that target lysine riboswitches.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (47.37)18.7374
1990's8 (42.11)18.2507
2000's1 (5.26)29.6817
2010's1 (5.26)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (2)

ArticleYear
Cytotoxicity and sister chromatid exchanges induced in vitro by six anticancer drugs developed in the People's Republic of China.
Journal of the National Cancer Institute, Volume: 71, Issue: 4
1983
Toxicity of oxalysine and oxalysine-containing peptides against Candida albicans: regulation of peptide transport by amino acids.
Journal of general microbiology, Volume: 138, Issue: 11
1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]